Evidence map›Paper›PMID 35840584›Full record

ArticleTranslational psychiatry2022

Perceived discrimination as a modifier of health, disease, and medicine: empirical data from the COVID-19 pandemic.

Moriah E Thomason, Cassandra L Hendrix, Denise Werchan, Natalie H Brito

Abstract read
In one paragraph

Article in Translational psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. When the World Pivots: Changes in Infant Negative Affect Trajectories Following the Onset of the COVID-19 Pandemic.Infancy : the official journal of the International Society on Infant Studies
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Moriah E ThomasonDepartment of Child and Adolescent Psychiatry, New York University Langone Health, New York, NY, 10016, USA. moriah.thomason@nyulangone.org.ORCID 0000-0001-9745-1147
Cassandra L HendrixDepartment of Child and Adolescent Psychiatry, New York University Langone Health, New York, NY, 10016, USA.ORCID 0000-0002-1462-3941
Denise WerchanDepartment of Child and Adolescent Psychiatry, New York University Langone Health, New York, NY, 10016, USA.
Natalie H BritoDepartment of Applied Psychology, New York University, New York, NY, 10003, USA.

Funding

8/24 The Healthy Brain and Child Development National ConsortiumU01DA055338 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Obianuju Berry, Lauren Christine Shuffrey · 2021 to 2026
$9.4M
Examining Prenatal Inflammation and Neurodevelopment in a Longitudinal Fetal-to-Age 9 Imaging Study - Administrative SupplementR01MH122447 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI THOMASON, MORIAH E, TRENTACOSTA, CHRISTOPHER J · 2020 to 2025
$3.9M
“Overlapping and Discrete Pathways Through Which Prenatal Isolation and Uncertainty Stress Impact Maternal Mental Health and Child NeurodevelopmentR01MH126468 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BRITO, NATALIE HIROMI, THOMASON, MORIAH E · 2021 to 2024
$3.0M
Investigating neurobehavioral consequences of COVID-19 related stressors on maternal mental health and infant developmentR01MH125870 · NIMH · NEW YORK UNIVERSITY · PI BRITO, NATALIE HIROMI, THOMASON, MORIAH E · 2021 to 2024
$2.9M
In Utero Assessment of the Human Neural Connectome and Later Child BehaviorR01MH110793 · NIMH · WAYNE STATE UNIVERSITY · PI THOMASON, MORIAH E · 2016 to 2021
$2.7M
From the womb to the classroom: Linking perinatal micronutrients and toxicants to neural and behavioral development in utero and in childhoodR01ES032294 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARTINEZ, MAURO, THOMASON, MORIAH E · 2020 to 2024
$2.6M
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)R34DA050287 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERGINK, VEERLE, THOMASON, MORIAH E · 2019 to 2021
$979k
NIDA NIH HHS DA050287NIDA NIH HHS DA055338NIDA NIH HHS R34 DA050287NIDA NIH HHS U01 DA055338NIEHS NIH HHS ES032294NIEHS NIH HHS R01 ES032294NIMH NIH HHS MH122447NIMH NIH HHS MH125870NIMH NIH HHS MH126468NIMH NIH HHS R01 MH110793NIMH NIH HHS R01 MH122447NIMH NIH HHS R01 MH125870NIMH NIH HHS R01 MH126468
6 · The paper itself

Abstract

Increasing reports of long-term symptoms following COVID-19 infection, even among mild cases, necessitate systematic investigation into the prevalence and type of lasting illness. Notably, there is limited data regarding the influence of social determinants of health, like perceived discrimination and economic stress, that may exacerbate COVID-19 health risks. Here, 1,584 recovered COVID-19 patients that experienced mild to severe forms of disease provided detailed medical and psychosocial information. Path analyses examined hypothesized associations between discrimination, illness severity, and lasting symptoms. Secondary analyses evaluated sex differences, timing of infection, and impact of prior mental health problems. Post hoc logistic regressions tested social determinants hypothesized to predict neurological, cognitive, or mood symptoms. 70.6% of patients reported presence of one or more lasting symptom after recovery. 19.4% and 25.1% of patients reported lasting mood or cognitive/memory problems. Perceived discrimination predicted increased illness severity and increased lasting symptom count, even when adjusting for sociodemographic factors and mental/physical health comorbidities. This effect was specific to stress related to discrimination, not to general stress levels. Further, patient perceptions regarding quality of medical care influenced these relationships. Finally, illness early in the pandemic is associated with more severe illness and more frequent lasting complaints. Lasting symptoms after recovery from COVID-19 are highly prevalent and neural systems are significantly impacted. Importantly, psychosocial factors (perceived discrimination and perceived SES) can exacerbate individual health risk. This study provides actionable directions for improved health outcomes by establishing that sociodemographic risk and medical care influence near and long-ranging health outcomes. All data from this study have been made publicly available.

Indexed as

COVID-19FemaleHumansMaleMental HealthPandemicsPerceived DiscriminationPrevalence

Identifiers

PMID35840584
PMCPMC9285192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.